These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 8824218

  • 21. 2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11.
    Waller SC, He YA, Harlow GR, He YQ, Mash EA, Halpert JR.
    Chem Res Toxicol; 1999 Aug; 12(8):690-9. PubMed ID: 10458702
    [Abstract] [Full Text] [Related]

  • 22. Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6.
    Kent UM, Sridar C, Spahlinger G, Hollenberg PF.
    Chem Res Toxicol; 2008 Oct; 21(10):1956-63. PubMed ID: 18729327
    [Abstract] [Full Text] [Related]

  • 23. Catalytic properties of an expressed cytochrome P450 2B1 from a Wistar-Kyoto rat liver cDNA library.
    Kobayashi Y, Strobel SM, Hopkins NE, Alworth WL, Halpert JR.
    Drug Metab Dispos; 1998 Oct; 26(10):1026-30. PubMed ID: 9763409
    [Abstract] [Full Text] [Related]

  • 24. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1.
    Shu L, Hollenberg PF.
    Carcinogenesis; 1997 Apr; 18(4):801-10. PubMed ID: 9111218
    [Abstract] [Full Text] [Related]

  • 25. Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide.
    Kumar S, Chen CS, Waxman DJ, Halpert JR.
    J Biol Chem; 2005 May 20; 280(20):19569-75. PubMed ID: 15774478
    [Abstract] [Full Text] [Related]

  • 26. Mechanistic studies of cytochrome P450 2B1 inactivation by xanthates.
    Yanev SG, Kent UM, Roberts ES, Ballou DP, Hollenberg PF.
    Arch Biochem Biophys; 2000 Jun 01; 378(1):157-66. PubMed ID: 10871056
    [Abstract] [Full Text] [Related]

  • 27. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
    Goosen TC, Mills DE, Hollenberg PF.
    J Pharmacol Exp Ther; 2001 Jan 01; 296(1):198-206. PubMed ID: 11123381
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-ethynylpyrene and phenylacetylene.
    Chan WK, Sui Z, Ortiz de Montellano PR.
    Chem Res Toxicol; 1993 Jan 01; 6(1):38-45. PubMed ID: 8448348
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Escherichia coli expression of site-directed mutants of cytochrome P450 2B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies.
    He YQ, He YA, Halpert JR.
    Chem Res Toxicol; 1995 Jun 01; 8(4):574-9. PubMed ID: 7548737
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F-G region in P450 2B1.
    Scott EE, He YQ, Halpert JR.
    Chem Res Toxicol; 2002 Nov 01; 15(11):1407-13. PubMed ID: 12437331
    [Abstract] [Full Text] [Related]

  • 36. The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1.
    Lin HL, Zhang H, Waskell L, Hollenberg PF.
    Chem Res Toxicol; 2005 Aug 01; 18(8):1203-10. PubMed ID: 16097793
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate.
    Kent UM, Yanev S, Hollenberg PF.
    Chem Res Toxicol; 1999 Apr 01; 12(4):317-22. PubMed ID: 10207119
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.